Announced
Completed
Financials
Tags
United States
Acquisition
Private
Friendly
Single Bidder
ophthalmology
Dry Eye Disease treatment
Pharmaceuticals
Majority
Completed
Cross Border
Synopsis
Nordic Pharma-backed Amring Pharmaceuticals, a privately held pharmaceutical company providing niche generics and value-driven brands, completed the acquisition of Visant Medical, a clinical-stage medical device company and Lacrifill® developer. Financial terms were not disclosed. “Visant is thrilled to be joining the Nordic Pharma group. Our team has been passionate about bringing a truly innovative solution to patients suffering from DED and we are excited to be joining the Nordic Pharma team as we begin our commercialization efforts,” Vartan Ghazarossian, Ph.D., Visant co-founder and CEO
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.